STRS Ohio’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

STRS Ohio’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-577	Closed	-$22K	–	2052
2016 Q3	$22K	Hold	577	–	–	﹤0.01%	1838
2016 Q2	$7K	Hold	577	–	–	﹤0.01%	1895
2016 Q1	$4K	Hold	577	–	–	﹤0.01%	1883
2015 Q4	$5K	Hold	577	–	–	﹤0.01%	1895
2015 Q3	$5K	Hold	577	–	–	﹤0.01%	1860
2015 Q2	$9K	Sell	577 -1	-0.2%	-$15	﹤0.01%	1838
2015 Q1	$6K	Sell	578 -11	-2%	-$118	﹤0.01%	1787
2014 Q4	$5K	Hold	589	–	–	﹤0.01%	1727
2014 Q3	$6K	Hold	589	–	–	﹤0.01%	1768
2014 Q2	$36K	Buy	+589	New	+$35.8K	﹤0.01%	1639

STRS Ohio's TBRA Position: Q4 2016 in Review

STRS Ohio sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 577 shares — an estimated $22K sold.

STRS Ohio first reported a position in TBRA in Q2 2014 and held it in 10 quarters. The position peaked at $36K in Q2 2014. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

STRS Ohio reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
STRS Ohio sold 577 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $22K.
STRS Ohio first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
STRS Ohio's Tobira Therapeutics, Inc. Common Stock position peaked at $36K in Q2 2014.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on STRS Ohio's 13F filing for Q4 2016, filed 24 Jan 2017.